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Abstract 
Nanotechnology is quickly becoming incorporated into everyday products 
and uses.  Silver nanoparticles, specifically, are being used in commercial 
products, to include aerosols.  The purpose of this research was to determine 
whether silver nanoparticles are toxic to human lung epithelial cells.  Different 
types (coated vs. uncoated), concentrations (10, 50, 100, and 200 µg/mL) and 
sizes (coated 5 and 80nm, uncoated 10 and 80nm) of silver nanoparticles were 
used during this study.  Toxicity measurements were completed through in vitro 
techniques.  Another study was also completed on toxicity mechanisms by 
measuring the reactive oxygen species (ROS) generated.  Results showed that 
silver nanoparticles induce mitochondrial toxicity through a size and 
concentration dependent manner. Increasing the concentration yielded increased 
toxicity and the smaller the size induced increased toxicity to the mitochondria.  
Results also showed that the uncoated nanoparticles were also more toxic to the 
cells than the coated nanoparticles.  The small nanoparticles (coated 5, uncoated 
10nm) induced more formation of the ROS than the larger nanoparticles (80nm). 
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IN VITRO TOXICITY OF SILVER NANOPARTICLES IN HUMAN LUNG 
EPITHELIAL CELLS 
 
 
I. Introduction 
1.1. Chapter Overview 
Nanoparticle research is an ever increasing scientific research interest, 
especially over the last couple decades.  Nanoparticles and nanomaterials are 
quickly becoming part of everyday lives.  Current applications are seen in many 
useful products:  water filters, hair appliances, socks, wound dressings, dental 
bonding agents, etc. (National Nanotechnology Initiative, 2008).  The Department 
of Defense is involved in developing the nanotechnology field.  For instance, the 
FY08 budget allocated for the national Nanotechnology Initiative was 
approximately $1.5 billion, with the Department of Defense (DoD) receiving 
almost $487 million.  The projected budget for FY09 is over $1.5 billion with a 
projected DoD allocation of $431 million (National Nanotechnology Initiative, 
2008).  Applications for Department of Defense can include the use of 
nanoparticles in chemical and biological defense and detection, as well as 
personal protective equipment. Further research in this area is needed to 
determine the extent nanoparticles will play in biological weapons of mass 
destruction (WMD) defense.  However, the toxicity associated with these 
nanoparticles has not been evaluated thoroughly.  This study links the potential 
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bioterrorism aspects and the toxicity of nanoparticles together while looking at 
the effects of the nanoparticle exposure on lung cells. 
   Nanoparticles are materials that measure between 1 and 100 
nanometers (nm) in one dimension.  Nanoscience involves investigation into 
learning new properties of nanosize materials (National Nanotechnology 
Initiative, 2008).  At the nanoscale, objects behave quite differently from those at 
larger scales.  Some nanoparticles may be toxic compared the bulk parent 
material.  For instance, gold at the bulk scale is an excellent conductor of heat 
and electricity, but not of light. Gold nanoparticles, on the other hand, have the 
ability to absorb light; therefore creating heat that can kill unneeded cells in the 
human body (National Nanotechnology Initiative, 2008).  This is due to the 
decrease in size and volume resulting increased surface area to volume ratio.  
The increased nanoparticle surface area can more readily interact with cells, 
producing harmful effects.   
1.2. Problem Statement 
 Nanoparticle research is a new area in the scientific community and is 
growing significantly.  Toxicity levels (observed effects or lethal concentration) 
have not been determined for most nanoparticles.  As this research field grows, 
the applications of nanoparticles are increasing.  Nanoparticle toxicity levels must 
be determined to keep the population safe.   
The present study is intended to determine cell viability in the presence of 
silver nanoparticles.  The cell viability will be assessed by determining 
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mitochondrial function and membrane leakage in human lung cells.  Furthermore, 
it is intended to determine the generation of reactive oxygen species (ROS) 
generated by the silver nanoparticles in the A549 (American Type Culture 
Collection, ATCC) lung epithelial cells.     
1.3. Research Questions 
1.  Are silver nanoparticles toxic to the A549 (ATCC) lung epithelial cells?   
 2.  Does the exterior coating of the nanoparticles affect toxicity? 
 3.  Does the size difference of the nanoparticles affect toxicity? 
1.4. Significance of Results 
The use of nanoparticles for defense and detection from weapons of mass 
destruction is a credible and working option for the DoD.  Understanding the 
results of this study and how silver nanoparticles can affect human lung cells at 
certain levels may be able to show us how to defend against or detect weapons 
of mass destruction, as well as how aerosols in industrial settings may affect 
human lungs.  Depending on the toxicity levels, nanoparticles could potentially be 
toxic when used for chemical or biological weapons defense and detection. 
1.5. Research Focus 
1. To determine the toxicity of silver nanoparticles based on size and coating 
in lung cell models.  
2.  To investigate the mechanisms of toxicity. 
3. Predict toxicity from in vitro to in vivo by using kinetic modeling approach.  
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1.6. Methodology 
1.6.1. Nanoparticles 
 Table 1 shows the different nanoparticles used during this study.  The 
nanoparticles were received from Clarkson University.  The nanoparticles are 
either:  coated or uncoated.  The coated nanoparticles have a polysaccharide 
coating.  The specifics of the polysaccharide coating are not known.  These two 
categories are further broken down to small (<10 nm) and large (80 nm) 
nanoparticles.  During this study, toxicity differences were observed based on the 
nanoparticle concentration, coating of the nanoparticle, and the size of the 
nanoparticle (small vs. large).  
Table 1.  Experimental Nanoparticles 
Silver Nanoparticles Small Large 
Coated  
(polysaccharide coating) 
10 nm 80 nm 
Uncoated 5 nm 80 nm 
 
1.6.2. Methods  
Several methods were employed throughout this research.  First and 
foremost was cell harvesting.  During cell harvesting, A549 (ATCC) human lung 
epithelial cells needed during the experimental process were cultured as 
described in Appendix A and in accordance with the ATCC guidelines. 
After completing cell harvesting, a growth curve of the cells was 
determined.  A549 cells were grown over seven days to determine the normal 
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growth rate without nanoparticle interference or interaction.  Along with the 
growth curve, the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyltetrazolium 
bromide) assay was used to determine the cell viability daily.  The assay was an 
indicator that the cells were still alive and growing throughout the growth curve 
period.  This is a colorimetric test measuring activity of enzymes that reduce MTT 
for formazan.  The MTT assay indicates cell viability through a yellow to purple 
color change, measured by a light absorbance reading at 490 nm. 
After the growth rate was determined, the cells were dosed with different 
nanoparticle concentrations for each different nanoparticle used.  The fist assay 
used was the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2-(4-
sulfonyl)-2H-tetrazolium, inner salt) assay.  This assay is also a colorimetric 
method used to identify the cytotoxic potential of the nanoparticles and determine 
cell viability via a light absorbance reading at 490 nm.   
The next assay used was the LDH (lactate dehydrogenase) assay.  This 
assay was used to determine the cell cytotoxicity by measuring the LDH leakage 
across the plasma membrane.  This assay also required a light absorbance 
reading at 490 nm. 
The last assay used was the reactive oxygen species (ROS) assay.  This 
assay measured the formation of ROS created by silver nanoparticle exposure.  
This assay used a fluorescence reading at an excitation wavelength of 485 ± 
20nm and an emission wavelength of 528 ± 20nm. 
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Transmission Electron Microscopy (TEM) was completed on the different 
nanoparticles to obtain the mean sizes (and standard deviation) and morphology 
of each different type.   
Dynamic Light Scattering (DLS) was used for characterization of the 
nanoparticle sizes and agglomeration of nanoparticles in solution.   
CytoViva™ was completed to observe the nanoparticle interaction with the 
cell line after 24 hours of exposure.   
1.7. Assumptions  
1. There is a uniform distribution of silver nanoparticles dosing of the lung 
epithelial cells, allowing for equal exposure of the cells to the nanoparticles. 
2. Cells dosed at the same concentration of silver nanoparticles each receive 
the same level of exposure throughout each assay. 
3. In vitro studies can give insight to in vivo studies, not give an exact 
determination of toxicity. 
The nanoparticles solutions were sonicated prior to making the dosing 
solutions for approximately 10-12 seconds.  Also, prior to dosing the cell plates, 
all solutions are stirred by a vortex stirrer to ensure even distribution in the 
solution. 
In vitro studies can only show correlation with in vivo studies, but cannot 
replace an experimental study that is done using in vivo techniques.  They can 
show some correlation to each other.  Both types of studies are compared during 
in the literature review (Chapter 2). 
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1.8. Implications 
 This study provides toxic or biological properties of silver nanoparticles 
based on their physicochemical properties.  The results will give insight to the 
material scientists to synthesize biocompatible and safe nanomaterials by 
modifying surface properties. 
1.9. Document Overview 
This paper studies the toxicity of silver nanoparticles in human lung 
epithelial cells.  It includes the use of several different assays to determine the 
toxicological effects on the cell line:  mitochondrial activity assay, membrane 
leakage assay, and reactive oxygen species assay.  Each type of assay was 
completed at least three times for statistical significance.  The assays are 
described in Chapter 3.  The results of the assays and characterizations are 
found in Chapter 4.   Conclusions drawn from this study are found in Chapter 5. 
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II. Literature Review 
2.1. Background 
 This chapter addresses the relevance of nanoparticles to bioterrorism 
detection and defense, to include historical bioterrorism.  The chapter also 
discusses nanoparticle characteristics and toxicity, followed with more specifics 
on silver nanoparticles used in this research.  It also addresses several 
applications that may be associated with nanoparticles, to include possible use 
as aerosols.  Each assay used during this experiment is also discussed. 
2.1.1  Bioterrorism 
Biological weapons are easier to develop, more lethal, inexpensive to 
produce, easier to deliver and the risk of detection is low as compared to 
chemical and nuclear weapons (Radosavljevic V. B., 2007).  These properties 
create the appeal of bioweapons to terrorists.  There are already many historical 
instances of the use of biological weapons, to include: 1) 14th Century Tartar 
besiegers were said to have catapulted plague infected corpses into the city of 
Kaffa, 2) smallpox contaminated blankets were given to Pro-French Indians by 
Lord Jeffery Amhurst, 3) Salmonella typhimurium poisoning of salad bars by the 
Rajneeshe Cult in Oregon in 1984, 4) Texan laboratory technician poisoned 12 of 
her fellow worker by inoculating Shigella dysenteriae into muffins and doughnuts 
in the staff room (Spencer, 2007). 
In 1972, the Biological and Toxin Weapons Commission (BTWC) placed 
restrictions on the use of biological materials or chemicals that can be linked to 
bioweapons or chemical weapons (Lee, Hadjipnanaysis, & Parker, 2005).  The 
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BTWC restricted the research of biological weapons to defensive research only; 
no offensive research was to be done thereafter. 
Although, the BTWC restricted offensive research of bioweapons, there is 
belief that there are countries developing these types of weapons.  In fact in 
1998, the US Commission on National Security in the 21st Century determined 
that biological agents were the most likely choice of weapons for rogue states 
(Radosavljevic & Jakovljevic, 2007).  Sadly, the U.S. has seen that this prediction 
was accurate during the anthrax attacks of 2001.  During the aftermath of the 
anthrax attacks there has been a focus on weapons of mass destruction, 
especially the biological and chemical weapons realms.  The anthrax attacks 
brought forth an old concern of weapons that have not been used in current 
times, at least not in the United States.   
It can be difficult to talk about a bioweapon without defining the term.  A 
bioweapon has been defined as the use of micro-organisms or the products of 
living organisms (toxins) cause damage on a population (Spencer, 2007).    The 
population affected can include people, animals and crops.  The use of these 
same micro-organisms as weapons can result in a major negative impact on a 
nation’s physical, psychological or economic well-being (Spencer, 2007).  This 
was seen throughout the timeframe of the anthrax attacks.  Nanoparticles could 
fall within this bioweapon category.  Although they are not living organisms, as 
discussed later, they can be products of many natural processes. 
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2.1.2. Nanoparticles and Bioterrorism Defense 
While the discussion of bioterrorism continues, nanoparticles will have 
their place in the development of combating future weapons.  Nanoparticles are 
abundant in nature.  They are produced in many natural methods, to include:  
photochemical reactions, volcanic eruptions, forest fires, and simple erosion, 
plants, and animals (Buzea & Blandino, 2007).  In future research the 
manipulation of these very small particles to defend against chemical or 
biological weapons will be a focus.  Can they be effectively used to defend 
against all routes of exposure (inhalation, ingestion or dermally absorbed)?  Or 
even used to predict exposure in the field?   
The DoD has begun research to start answering these questions and has 
a nanotechnology defense program.  The long term objective for DoD in the 
nanotechnology defense programs is:  ‘to discover and exploit unique 
phenomena at these dimensions to enable novel applications enhancing war 
fighter and battle systems capabilities’ (Department of Defense, 2007).  In 2002 
the U.S. Army Research Office contracted with the Massachusetts Institute of 
Technology (MIT) to found the Institute for Soldier Nanotechnologies (ISN) 
(Massachusetts Institiute of Technology, 2008).  This partnership was originally 
contracted for five years, but has been extended for another five years.  The 
mission of the ISN is ‘to create better survivability materials to protect today’s 
Soldiers’, specifically using nanomaterials (Massachusetts Institiute of 
Technology, 2008).  The ISN addresses the questions from the previous 
paragraph and has been working on the development of better chemical and 
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biological weapons defense equipment.  ISN has a Strategic Research Area 
(SRA) dedicated to the Chemical/Biological Materials Science with a focus in 
Detection and Protection (Massachusetts Institiute of Technology, 2008).  This 
shows that research in this field has already expanded to the DoD, making 
further research in nanoparticles possible and important to the warfighter. 
2.2. Nanoparticles 
2.2.1. Overview 
 Nanoparticles, as defined earlier, are particles with at least one dimension 
less than 100 nm.  Nanoparticles have a large surface area that can interact with 
the environment.  For instance, a size reduction from 10 microns to 10 
nanometers will increase the contact surface area by 109 (Pal, Tak, & Song, 
2007). This increases the contact surface area with which the particle can 
interact with other matter:  tissues, organs, and cells, for instance.  In Figure 1, 
the photo shows how a nanoparticle size compares to other objects.  According 
to Figure 1, a strand of hair is 100,000 times the width of a nanometer, knowing 
this can put nanoparticle experiments into a relative perspective. 
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Figure 1.  Scale of Nanoparticles Compared to Other Objects (from 
http://www.nano.gov/html/facts/nanoscale.html) 
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As the industrial use of nanoparticles increases, so do the opportunities 
for biological interaction of the nanoparticles to human cells.  This interaction 
may be dermal, through ingestion, or through inhalation.  This study looks mainly 
at the inhalation concern, but also considers the other two areas and they will be 
discussed later in this chapter through the examples of previous studies.  
Knowing the effects through these routes may give some insight into predicting 
the effects on human lung cells.   Most studies of silver nanoparticle toxicity are 
in vitro studies as opposed to in vivo studies.   Although this is the case, an in 
vivo study will also be discussed later in the chapter. 
2.2.2. Silver Nanoparticles 
  Silver has been used extensively for its antimicrobial properties in wound 
dressings in order to fight infection as it is a safe, inorganic antibacterial agent.  
Silver (including its ions and compounds) has been researched thoroughly for 
toxicity, which in extremely small concentrations is nontoxic to human cells (Pal, 
Tak, & Song, 2007).  Silver (and its ions and compounds) is capable of killing 
about 650 types of disease-causing microorganisms (Raffi, Hussain, Bhatti, 
Akhter, Hameed, & Hasan, 2008).  Although nano-silver is highly toxic to 
microorganisms, it shows a low toxicity toward mammalian cells.  Raffi, et al. 
(2008) calls nano-silver ‘oligodynamic’ due to its ability to exert a bactericidal 
effect at minute concentrations.   
 A study by Raffi, et al. (2008) conducted tests on the antibacterial 
properties of nanosilver.  They observed the growth of Escherichia coli (E. coli) 
under differing concentrations of silver nanoparticles. Silver nanoparticles in 
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concentrations greater than 60 µg/mL were found to be effective bactericides 
(Raffi, et al., 2008).  Essentially, no growth of the E. coli was observed in trials 
with a concentration greater than this.  The number of remaining colony forming 
units (CFUs) was inversely related to the concentration of silver nanoparticles. 
 In another study, scientists conducted an in vivo toxicology study of silver 
nanoparticle effects on zebrafish embryos.  According to Berger (2008), the 
researchers determined that silver nanoparticles have a high probability to induce 
health and ecotoxicity issues in a concentration dependent mode.  They found 
that in concentrations greater that 50 µg/mL nanosilver treated embryos showed 
visible signs of defects and altered physiological functions (slower heart rate, 
axial curvatures and body part function loss) (Berger, 2008) (Asharani, Wu, 
Gong, & Valiyaveettil, 2008).  It was not established, though, that silver 
nanoparticles crossed the blood-brain barrier of the embryos. 
In both studies, the E. coli and zebrafish embryo studies, the findings 
showed similar silver nanoparticle concentrations that exhibited toxic effects.  
These toxic level concentrations (60 µg/mL and 50 µg/mL, respectively) are 
within a close proximity.  The greater concentration was found in the in vitro 
study and the lower in the in vivo study, showing some correlation with the in 
vitro and in vivo toxicity studies. 
 In other studies, silver nanoparticle interactions with mitochondria have 
been observed.  Silver nanoparticles have been shown to be linked to decreasing 
mitochondrial activity in cells (Chen & Schluesener, 2008).  This is important 
since mitochondria are often referred to as the powerhouse of the cell.  They 
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produce the energy required for the cell to function.  The cristae (inner 
mitochondrial folds) and the matrix are involved in, and have different 
responsibilities, during the energy producing functions of the mitochondria.  
Figure 2 shows a picture of a mitochondrion and its parts.  The cristae (the inner 
folds of the mitochondria) and the inner membrane contain the molecules that 
serve as the electron-transport chain during aerobic respiration (Fox, 2006).  This 
chain donates the electrons to the oxygen in the final oxidation-reduction reaction 
in the electron-transport chain. The mitochondria are also involved in the 
formation of the reactive oxygen species in cells.  Reactive oxygen species will 
be discussed in depth in section 2.6.4. 
 
Figure 2.  Cell Mitochondria 
Outer Membrane
Inner Membrane
Cristae
Matrix
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Silver nanoparticles are considered cytotoxic and cell exposure is 
considered to be an early step in apoptosis.  The mechanism(s) linked to silver 
nanoparticle cytotoxicity is not completely understood.  Raffi et al. (2008) suggest 
that, in the study of E. coli, bacteria change membrane morphology producing a 
significant increase in permeability affecting proper transport through the plasma 
membrane. They observed that the silver nanoparticles penetrated into the 
bacteria causing damage by interacting with phosphorus and sulfur containing 
compounds, like DNA, and resulting in cell death (Raffi, Hussain, Bhatti, Akhter, 
Hameed, & Hasan, 2008).   
Chen and Schluesener (2008) agreed that silver nanoparticle interaction 
with the thiol groups of the mitochondrial inner membrane occurs.  They 
indicated that this leads to the depletion of the antioxidant defense mechanism 
which, in turn, led to the formation of ROS.  The ROS accumulation leads to an 
inflammatory response.  The cells’ inflammatory response initiated the 
destruction of mitochondria, which provoked the release of apoptogenic factors 
that induce cell death (Chen & Schluesener, 2008). 
Supporting these studies is a study by Hussain et al. (2005) who looked at 
toxic response of silver nanoparticles (15 and 100 nm) in BRL 3A rat liver cells.  
They found that silver nanoparticles induce a toxic response in this cell type.  
Also, they determined that mitochondrial function diminished considerably in cells 
exposed to silver nanoparticles at 5-50 µg/mL (Hussain, Hess, Gearhart, Geiss, 
& Schlager, 2005).  It was also determined that there was significant LDH 
leakage across the membrane in cells exposed to silver nanoparticles from 10-50 
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µg/mL (Hussain, et al., 2005).  It was observed that along with the reduced 
mitochondrial membrane potential, there was an increase in ROS levels 
suggesting that the cytotoxicity of nanosilver was probably mediated through 
oxidative stress (Hussain, et al., 2005).  Also, the team observed that there was 
an increase in ROS generation with an increase in nanoparticle concentration.  
The study showed that after an exposure of 24 hours, the cells showed a 
concentration dependent LDH leakage with significant cytotoxicity at 10-50 
µg/mL (Hussain, et al., 2005). This team not only studied silver nanoparticles, but 
also other nanomaterials (MoO3, Al, Fe3O4, and TiO2).  They determined through 
the use of MTT and LDH assays that the silver nanoparticles were more toxic 
than the other nanomaterials noted above.   
2.3. Health and Safety 
 Silver has a high degree of use in the medical field.  Severe side effects 
are a rare occurrence from silver poisoning, which is one reason for its common 
medical usage.  When silver poisoning does occur, it only occurs in chronic 
history of silver exposure (Chen & Schluesener, 2008).  As its use as 
nanoparticles increases, the study of the silver nanoparticle interaction in the 
human body becomes of greater importance as well as the different routes of 
exposure.  Also, as the use of nanoparticles in the medical field increases, so 
does the probability of the silver nanoparticles interacting with human organs, 
tissues, and cells (Chen & Schluesener, 2008).  There are few studies of how 
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silver nanoparticles interact with the different biological entities (organs, tissues 
and cells) of the human body.   
A case in point is the use of silver salt. Silver salt commonly has been 
used in bone cement.  In a 2004 study, the scientists looked at how silver salt 
fought infections as opposed to how silver nanoparticles fought bacteria (Alt, et 
al., 2004).  Silver salts in polymethylmethacrylate (PMMA) bone cement were 
found to be highly cytotoxic to osteoblasts (bone cells), but could still fight off 
infections.  After using the silver nanoparticles, many of the infections were 
reduced along with the reduction of the cytotoxic effects to osteoblasts.  Figure 3 
shows the differences in the cytotoxicity and antibacterial effects of the different 
types of silver.  As can be observed, the silver salts have both high antibacterial 
properties and high cytotoxic effects:  whereas, the silver nanoparticles have high 
antibacterial effects and low cytotoxicity.  According to this study, the silver 
nanoparticles are the better material to use since they show the lowest 
cytotoxicity to osteoblasts. 
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Figure 3.  Overview of Cytotoxicity and Antibacterial Properties of Silver 
Salts versus Nanosilver Use in Bone Cement (modified from Alt, et al., 
2004) 
 
Silver nanoparticles can also be ingested into the body.  Ingestion is a 
common route of intake. Silver nanoparticles are found in ‘health maintainers’ or 
‘immuno-boosters’, water disinfection products and food stabilization products 
(Chen & Schluesener, 2008).  These uses have increased the amount of silver 
nanoparticles available to be ingested by the population.  Increased ingestion 
increases the availability of distribution of the nanoparticles to the cells.  This 
may also lead to a greater formation of ROS in cells, which, as stated earlier, can 
lead to cell death.   Without knowing the effects of the nanoparticles extensively, 
the lethal limit cannot be known. Ingesting chronic doses of silver can lead to 
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argyria whose most striking symptom is a bluish-grey skin color (Goyer & 
Clarkson, 2001).    
The concern for this study is the inhalation exposure effects.  With the 
increase in the industrial production, the general population involved may be 
exposed to nanoparticles in the air.  Knowing how this affects the lung cells will 
be helpful in determining protective gear as well as the limits of exposure to 
humans. 
2.4. Surface Characteristics 
 The most important characteristic of a nanoparticle is its small size.  This 
small size allows for the increased surface area (to volume ratio) that is readily 
available for reactions (Chen & Schluesener, 2008).  It also allows for greater 
particle mobility in the environment and the body.  The small size gives way for 
different entry points into the body:  ingestion, inhalation, and/or dermal 
absorption.  With respect to inhalation, the small size allows for the particulates 
to make it through the nasal-pharyngeal region to the alveolar region of the 
respiratory system. Particles smaller than 2.5 microns, generally, are able to 
traverse into this region.  Nanosilver may be able traverse through the nasal 
pharyngeal region into the alveolar region.  Once in this region, nanoparticles can 
be distributed throughout the body (via the circulatory system, for example) 
where they can initiate different types of tissue responses, such as:  cell defense 
activation, ROS generation, inflammation, and possibly cell death (Chen & 
Schluesener, 2008).  Chen also states that several studies have shown that the 
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after inhalation of minute silver nanoparticle concentrations, the concentration in 
the lungs diminishes quickly.  Silver nanoparticles were consequently detected in 
the blood and other organs (heart, liver, kidney, and brain) (2008).  This is an 
indicator of how quickly nanosilver can be distributed through the body from the 
respiratory system to the circulatory system after inhalation. 
 The nanoparticles used during this research are either ‘coated’ or 
‘uncoated’.  According to Dr. Kyung Yu (2008) it is expected that the ‘uncoated’ 
nanoparticles are more toxic to cell mitochondrial activity than the respective 
‘coated’ nanoparticles.  The previous research on other nanoparticles has shown 
that this is the case with the different nanoparticles that they have tested (Yu, 
2008).  The ‘coated’ nanoparticles have a protective coat surrounding each 
nanoparticle.  In this study, the ‘coated’ nanoparticles are coated with 
polysaccharides.    
2.5. Nanotoxicity and Bioterrorism 
Nanoparticles can be inhaled, like aerosols.  Aerosols can move through 
the nasal-pharyngeal region, bronchial region, into the alveolar region, depending 
on size.  After inhalation, nanoparticles can deposit throughout the entire 
respiratory tract, starting in the nose and the pharynx, down to the lungs (Buzea 
& Blandino, 2007).  Larger particles will naturally deposit in the nose and 
pharynx, or at the branch points in the respiratory system. The smaller particles, 
less than 2.5 microns, may make it through the lungs and alveolar region.   With 
nanoparticles, as small as they are, they can easily move into the alveolar region.   
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The alveolar region has a very large surface area for nanoparticles to 
interact upon.  If these small nanoparticles move to the alveolar region, they can 
be circulated throughout the body.  They can then be found distributed through to 
the heart, blood and other organs.  Nanoparticles also can be found inside cells 
after entering a biological entity (like organs).  Once inside the cells, they can 
enter the cytoplasm, mitochondria, lipid vesicles, the nucleus and other 
organelles.  Cellular uptake and capability to form oxidative products depend on 
the particular nanoparticle chemistry, size and shape (Buzea & Blandino, 2007).   
They can cause cell damage or even cell death.  In Figure 4, the different 
pathways that nanoparticles may follow once inside the cells can be observed.   
Nanoparticles not only can be inhaled, but also can penetrate through 
dermal barriers or be ingested to enter the circulatory systems.  Dermal exposure 
can come through wound dressings.  In a wound dressing, there is direct access 
into the body through the wound.  Once foreign entities enter into the circulatory 
system, they can affect any part of the body, including the heart and the brain.  
One concern for the ingestion of nanoparticles is through water contamination.  
Animal ingestion of such contaminated products that have used these 
contaminated systems can pose a threat potential to the population.   
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Figure 4.  Schematics of the molecular events by which nanoparticles (NP) exert 
their toxic effects at the cellular level (modified from Buzea & Blandino, 2007) 
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2.6. Cellular Assays 
2.6.1. MTT Assay  
 The MTT (yellow MTT – (3-(4,5-Dimethylthiazol-2-yl)-2,5 
diphenyltetrazolium bromide))  assay measures the formation of formazan by 
cells.  This assay is a colorimetric test measuring the activity of enzymes that 
reduce MTT to formazan which indicates cell viability at an absorbance reading 
at 490nm.  MTT also measures the cell mitochondrial activity where the reduction 
to formazan takes place.  This conversion to formazan is often used as a 
measure of viable (living) cells.   
2.6.2. MTS Assay 
 The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2-
(4-sulfonyl)-2H-tetrazolium, inner salt) assay is a colorimetric method to identify 
the cytotoxic potential of the nanoparticles and determine cell viability by reading 
the absorbance at 490nm.  MTS is chemically reduced by cells to formazan 
which is soluble in tissue culture medium.  The assay measures dehydrogenase 
enzyme activity found in metabolically active cells (Promega).  In this chemical 
process, reducing compounds (NADH or NADPH) pass electrons to an 
intermediate electron transfer reagent that can reduce the tetrazolium product, 
MTS, into an aqueous, soluble formazan product.  Cells rapidly cannot reduce 
tetrazolium products after death (Promega, 2006).  The production of formazan is 
proportional to the number of living cells; the intensity of the produced color is a 
good indication of the viability of the cells (Promega).  The initial color of the MTS 
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solution is yellow.  After incubation, the purple color produced is the formazan, 
the indication of cell viability. 
The MTS assay is being used more than MTT due to time of exposure and 
amount of resources required.   The use of DMSO for solublization of the MTT is 
another reason that MTS is favored.  The MTS assay requires a 96-well plate 
which can be used to test more concentrations at once with only 200 µL of 
solution needed per well. The MTT assay requires the use of either 6-well or 24-
well plates to accommodate the 0.5 mL of solution needed for each well.  In this 
study, the 6-well plates were used during the growth curve determination. 
2.6.3. LDH Assay 
 The LDH assay is used to determine cell cytotoxicity by measuring the 
lactose dehydrogenase (LDH) leakage across the plasma membrane.  LDH is a 
cytoplasmic enzyme that is released into the cytoplasm upon cell lysis 
(Nanotechnology Characterization Laboratory, 2006).  It is considered to be a 
measure of membrane integrity.  Cells that lose membrane integrity release 
lactate dehydrogenase. According to the Nanotechnology Characterization 
Laboratory the basis of LDH assay is that:  
1)  LDH oxidizes lactate to pyruvate,  
2)  Pyruvate reacts with the tetrazolium salt INT to form formazan, and  
3) The water-soluble formazan dye is detected spectrophotometrically 
(2006).   
The increase in the amount of formazan correlates directly to the increase in the 
number of lysed cells (Biovision, 2008).   
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2.6.4. Reactive Oxygen Species (ROS) Assay 
Many studies, both in vivo and in vitro, have shown that nanoparticle 
toxicity can induce the formation of reactive oxygen species.  Reactive oxygen 
species have been shown to damage cells by peroxidizing lipids, altering 
proteins, disrupting DNA, interfering with signaling functions and modulating 
gene transcription (Buzea & Blandino, 2007).  Oxidative stress can be a 
response to cell injury.  Generally, small amounts of ROS are made in the cell 
through physiological processes, one of which is the electron transport chain 
within the mitochondria.  During this process, molecular oxygen is reduced one 
electron at a time (Boelsterli, 2007).  Figure 5 shows the stepwise reduction of 
oxygen in cell mitochondria. Partially reduced oxygen species may break away 
from the usual electron transfer process within the mitochondria (Boelsterli, 
2007). This creates a steady small amount of ROS inside the cell.  ROS are 
generated within the cell to a degree through the reduction-oxidation cycling of 
outside entities, xenobiotics (silver nanoparticles in this study). This occurs 
through the separation of monooxygenases or by rerouting the electrons from the 
electron transport chain (Boelsterli, 2007). 
 
 
Figure 5.  Stepwise reduction of oxygen (modified from Boelsterli, 2007) 
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Xenobiotics have been shown to increase the ROS production.  They do this 
through penetration into the mitochondria and interfering with the electron 
transport chain, thus blocking normal electron flow (Boelsterli, 2007).  The 
xenobiotics can also induce oxidative stress thereby causing the oxidation of the 
nucleic acids within the cell.  Figure 6 shows an overview of what happens within 
the cell after the ROS have been formed.  The ROS induce the antioxidant 
response of the cell, causing damage to DNA.  The damaged DNA either repair 
themselves or cause further damage to the cells. 
 
Figure 6.  Oxidative DNA Damage Can Lead to Apoptosis  
(Modified from Boelsterli, 2007) 
 
Because of the mitochondria naturally generates ROS, the mitochondrial 
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damage.  As a result of this inefficiency, the mitochondrial DNA amass more 
oxidatively damaged bases (Boelsterli, 2007).  But there are numerous copies of 
mitochondrial DNA and numerous mitochondria in the cell; this far outweighs the 
general oxidative event that may occur to the mitochondria.  When adding the 
additional creation of ROS through a xenobiotic it can be expected that the 
mitochondria will not be able to survive the mass amount of ROS production. 
2.7. Current Research and Applications 
Research in nanoparticles has increased dramatically over the last couple 
decades. While all the applications of nanoparticles will not be mentioned, the 
following applications show the wide array of products that nanoparticles are 
being used in currently. 
Products using nanoscale materials now available include:  anti-bacterial 
wound dressings (use nanoscale silver), water filtration, catalysis, dental bonding 
agent, step assists on vans, bumpers and catalytic converters on cars, 
sunscreens and cosmetics, and dry powder that can neutralize gas and liquid 
toxins in chemical spills and elsewhere (National Nanotechnology Initiative, 
2008). Research in nanomedicine, for instance, is focused on finding new ways 
for diagnosing and treating disease (National Nanotechnology Initiative, 2008).  
Inorganic nanoparticles generally possess versatile properties suitable for cellular 
delivery, including a wide availability, rich functionality, good biocompatibility, 
potential capability of targeted delivery, and controlled release of carried drugs 
(Xu, Zeng, Lu, & Yu, 2006). Other uses are in carbon nanotubes (CNTs) and 
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nanofilms (eyeglasses, computer displays, and cameras to protect or treat the 
surfaces) (National Nanotechnology Initiative, 2008).  Also, there is research that 
incorporated the use of silver nanoparticles in fighting HIV.  The researchers 
found that silver nanoparticles undergo a size dependent interaction with human 
immunodeficiency virus type 1 (Pal, Tak, & Song, 2007).  As seen with this 
example and the bone cement study, medical research is an important sector of 
the nanotechnology development. 
 There are few studies look at the interaction of silver nanoparticles and 
their biodistribution and organ accumulation, as well as the tissue interaction and 
toxicological implications (Chen & Schluesener, 2008), but the field is growing.  
Studies still need to be completed on the transdermal considerations of 
nanosilver toxicity especially since they have use in the clothing industry (socks) 
and the medical field (wound dressings). 
Lastly, the DoD, in conjunction with the ISN, is looking at improving 
Soldier survivability in the field/wartime environments.  The development of a suit 
that is self contained and can detect and protect from chemical or biological 
weapons of mass destruction is on their developmental horizon (PennWell 
Corporation, 2003). 
2.8. Summary 
Silver nanoparticles are beginning to, and have begun to be used in many 
products.  Not only are these nanoparticles being used by civilians, but also, the 
Department of Defense has begun researching its own applications for silver and 
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other nanoparticles.  With so few studies showing how these nanoparticles 
interact biologically in humans, it cannot be understood what the potential risks 
may be.  Research of this nature can assist in the building blocks of learning how 
these nanoparticles may interact biologically in humans.  This study begins to 
look at how silver nanoparticles interact with human lung cells. 
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III. Methodology 
3.1. Introduction 
The goal of this research was to determine if silver nanoparticles are toxic 
to human lung epithelial cells.  This was carried out through in vitro methods that 
initially used MTS assays to determine mitochondrial activity and cell viability. 
LDH assays were used to determine the membrane leakage of the cells.  ROS 
assays were conducted to determine the presence or evolution of reactive 
oxygen species in the cell line.  Each assay required cell culturing and splitting 
prior to starting.  Therefore, the assays were started on a day which cell splitting 
was completed.   
Each assay used a positive control solution that either was another 
nanoparticle solution (MTS and LDH) or hydrogen peroxide solution (ROS).  The 
positive control was used to monitor the assays for proper readings, as well as to 
ensure that they were working in the method that was expected.  By comparing 
the results of the positive control to the nanoparticle readings, it could be 
determined if the assay was working properly for each trial.   
Each assay was completed in triplicate to conduct statistical analysis.  The 
steps for cell culturing, growth curve determination and each separate assay are 
listed in detail in Appendices A-F. 
Along with the assays previously listed, Dynamic Light Scattering (DLS), 
Transmission Electron Microscopy (TEM), and CytoViva™ characterization 
analyses were performed on the cells and/or the different silver nanoparticles.  
These results are also shown in this chapter. 
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3.2. Assumptions 
 There are several key assumptions that were made prior to the 
experimental process. 
1. An equal distribution of silver nanoparticles occurs after cell dosing, 
giving equal exposure to each nanoparticle to epithelial cells. 
2. Cells dosed at the same concentration of silver nanoparticles each 
receive the same level of exposure throughout each assay. 
3. In vitro studies can give insight to in vivo studies. 
3.3. Cell Lines 
 The cells used during this experiment were from the American Type 
Culture Collection (ATCC) (Manassas, VA), Number CCL-185, Designation 
A549.  The A549 cell line is from human lung epithelial (carcinoma) cells, with an 
initial isolation date in 1972.  These cells were chosen to look at possible 
inhalation exposure toxic effects upon the lungs. 
3.4. Cell Culture and Splitting 
A549 (ATCC) lung epithelial cells were cultured in accordance with the 
ATCC Protocol found in Appendix A (ATCC, 2008). One change to the ATCC 
protocol was to use a 5 mL rinse with Phosphate Buffer Solution (PBS) after the 
initial aspiration.  Cell splitting was conducted every three to four days at 
confluence.  Cell confluence was determined by observation through a light 
microscope. 
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3.4.1. Growth Curve 
A549 cells were grown over a specified length of time to determine the 
normal growth rate of the cells without nanoparticle interference. This experiment 
started with a solution of 100,000 cells/mL in growth media.  The cell growth was 
monitored over seven days.  Each day the cells were counted to determine 
growth change from day to day using a standard hemocytometer and light 
microscope.  Along with the cell counting, a cell viability assay was conducted.  
The MTT assay was used to determine the viability of the cells each day using an 
absorbance reading at 490 nm.  The blank measurement used for this assay was 
acidified-isopropyl alcohol (IPA).  A growth curve was determined using the data 
from the daily cell counts.  A full outline of the procedure is found in Appendix B. 
3.5. Absorbance and Fluorescence Readings 
 The absorbance of the materials was read on a Biotek® Synergy HT plate 
reader.  The readings were taken at 490 nm for MTT, MTS, and LDH Assays.  
The ROS fluorescence was read at an excitation wavelength of 485 ± 20 nm and 
an emission wavelength of 528 ± 20 nm from the bottom of the plate.   The 
results were exported into a Microsoft® Excel spreadsheet for calculations. 
3.6. Nanoparticles 
 The nanoparticles were received from Clarkson University.  The coating 
on the ‘coated’ nanoparticles is a polysaccharide coating.  Table 2 shows the 
different types and concentrations of silver nanoparticles used throughout this 
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experiment.  The nanoparticle solutions were made in exposure media.  The 
exposure media for the MTS and LDH assays were the same.  The exposure 
media used during the ROS assay was a colorless version of exposure media 
(discussed in Section 4.2.5.). These concentrations indicated in Table 2 were 
used during the MTS, LDH and ROS assays.   
 
Table 2  Expe.rimental Nanoparticle Sizes and Concentrations 
Nanoparticles Control 
 
Dosing Concentrations  
(µg of nanoparticle per mL of solution) 
Coated 
(5 nm & 80 nm) 
0 µg/mL 10 µg/mL 
 
50 µg/mL  100 µg/mL  200 µg/mL  
Uncoated 
(10 nm & 80 nm) 
0 µg/mL 10 µg/mL 
 
50 µg/mL  100 µg/mL  200 µg/mL  
 
  
In Figure 7, the nanoparticle solutions have been made for dosing 96-well 
plates for an assay.  From left to right are: uncoated 5 nm, uncoated 80 nm, 
coated 10 nm, and coated 80 nm in the dilutions given above in Table 2. From 
closest to furthest in columns are dilutions of 10 µg/mL, 50 µg/mL, 100 µg/mL, 
and 200 µg/mL. 
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Figure 7.  Nanoparticle Solutions Prepared for Dosing Plates 
3.7. MTT Assay 
The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide) 
assay  was used to determine the viability of the cells by reading the absorbance 
reading at 490 nm.  The control was acidified-isopropyl alcohol (IPA).  It is a 
colorimetric test used to measure activity of enzymes that reduce MTT for 
formazan (yields a purple color).  The initial color of the MTT solution is yellow.  
After incubation the reaction yields a purple color of the solution.  The intensity of 
the color indicates the amount of viable cells.  This assay was completed in 
accordance with Appendix C.  The absorbance was read on a Biotek® Synergy 
HT Plate reader.  The results were exported to and graphed on Microsoft® Excel 
software. 
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This assay was used during the growth curve determination.  It was used 
to determine the viability of the cells during the growth curve only.  The MTS 
assay was used for all calculations and determinations of cell viability during the 
rest of the study. 
MTT solutions were kept in light protected vials in a refrigerator at 4°C.  
The MTT solution was made by dissolving 10 mg of MTT powder into 20 mL of 
PBS. 
3.8. MTS Assay 
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2-(4-
sulfonyl)-2H-tetrazolium, inner salt) (Promega, 2006) assay is a colorimetric 
method to identify the cytotoxic potential of the nanoparticles and determine cell 
viability using an absorbance reading at 490 nm.  The MTS solution (Promega, 
CellTiter 96® AQueous One Solution Reagent) starts as a yellow solution.  After 
incubation, dependent on the amount of viable cells, the solution changes to a 
purple color.  The intensity indicates viability. This procedure was done in 
accordance with Appendix D and completed in triplicate.  The control medium 
used was exposure media.  The positive control used was a Cadmium Dioxide 
nanoparticle solution. The absorbance was read on a Biotek® Synergy HT Plate 
reader at 490 nm.  The results were exported to and graphed using Microsoft® 
Excel software. 
MTS solutions were kept in light protected vials in a refrigerator at 4°C.   
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3.9. LDH Assay 
The LDH assay was used to determine cell cytotoxcity through measuring 
the lactose dehydrogenase leakage across the plasma membrane.  This 
procedure was completed in accordance with Appendix E and the Promega® 
protocol.  The control used was exposure media.  The positive control used was 
a Cadmium Dioxide solution in exposure media.  The absorbance was read at 
490 nm on a Biotek® Synergy HT Plate reader.  The results were exported to 
and graphed on Microsoft® Excel software.  
3.10. Reactive Oxygen Species (ROS) Assay 
The ROS assay measures the formation of reactive oxygen species by 
nanoparticle interaction in the cells.  The procedure references the methods used 
in Wang & Joseph (1999) and can be found in detail in Appendix F.  This method 
uses DCFH-DA (2’,7’– dichlolorodihydrofluorescein diacetate).  The theory 
behind using DCFH-DA is that the non-fluorescent fluorescin derivatives will emit 
fluorescence after being oxidized  (Wang & Joseph, 1999). During this assay, 
hydrogen peroxide was used as the positive control.  After being applied to intact 
cells, the non-ionic, nonpolar DCFH-DA crosses cell membranes and is 
hydrolyzed enzymatically by intracellular esterases to nonfluorescent DCFH.  In 
the presences of reactive oxygen species, DCFH is oxidized to highly fluorescent 
dichlorofluorescein (DCF) (Wang & Joseph, 1999).   
  The fluorescence of the cells was read on a Biotek® Synergy HT plate 
reader.  The excitation filter was set at 485 ± 20 nm and the emission filter was 
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set at 528 ± 20 nm and set to read the plate from the bottom.   The results were 
exported to and graphed on Microsoft® Excel Software. 
3.11. Dynamic Light Scattering and Transmission Electron Microscopy  
Transmission electron microscopy (TEM) characterization was performed 
to obtain nanoparticle size and morphology on a Hitachi H-7600 tungsten-tip 
instrument at an accelerating voltage of 100 kV.  Nanoparticles were examined 
after suspension in water (1 mg/mL) and subsequent deposition onto 
formvar/carbon-coated TEM grids (~10 µL).  Image J was used to measure 
nanoparticles after TEM imaging with proper scale calibration.  Information on 
mean size and standard deviation was calculated from measuring over 100 
nanoparticles in random fields of view in addition to images that show general 
morphology of the nanoparticles.   Mr. Craig Murdock performed all TEM 
measurement analysis during this research. 
Dynamic light scattering (DLS) (for characterization of nanomaterial size 
or agglomeration of the nanoparticles in solution) was performed on a Malvern 
Instruments Zetasizer Nano-ZS instrument.  The device uses a 4mW He-Ne 
633nm laser to analyze the samples.  Samples were prepared as previously 
described  above in the TEM section and vortexed to provide a homogeneous 
solution, and then 1.5 mL was transferred to a square cuvette for DLS 
measurements.  Solutions were made at a concentration of 50 μg/mL for 
measurement.  The Malvern Zetasizer Nano-ZS uses the Dispersion Technology 
Software (V4.20) for data collection and analysis.  The mean particle diameter is 
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calculated by the software from the particle distributions measured and the 
polydispersity index (PdI) given is a measure of the size ranges present in the 
solution (Malvern Instruments Ltd., 2005).  The PdI scale ranges from 0 to 1, with 
0 being monodisperse and 1 being polydisperse.  The software calculates the 
PdI value from the G1 correlation function and from parameters defined in the 
ISO standard document 13321:1996 E.  Mr. Craig Murdock performed all DLS 
measurement analysis during this research. 
3.12. CytoViva™ 
 After counting the cells, a solution of 150,000 cells/mL was made in 
growth media.  One milliliter of the solution was added to each half of a two-
chamber polystyrene vessel culture slide, tissue culture treated glass slides (BD 
Falcon).  The slides were then incubated for 24 hours at 37°C.   
After 24 hours of incubation, the slides were aspirated and washed with 
1mL of PBS.  A 10 µg/mL dosing solution was prepared for each nanoparticle 
type (Uncoated 5 nm and 80 nm; Coated 10 nm and 80 nm).   One milliliter of 
each nanoparticle solution was added to the appropriate slide.  The slides were 
then incubated for 24 hours.  One milliliter of exposure media (F-12K Medium, 
Kaighn’s Modification of Ham’s F-12 with 1% Penicillin/Streptomycin) was used 
in the control slide.  The slides were then incubated for 24 hours at 37°C. 
After 24 hours of incubation, the media was aspirated from the culture 
slides and washed with 1 mL of 1xPBS.  The PBS was aspirated from the slides.  
Then, the chambers were removed from the slides.  Seven microliters of PBS 
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was added to each side of the slide and covered with a cover slip. The cells were 
evaluated (on glass slides with cover slips) using the 60x oil lens and were 
imaged with an Olympus IX71 Microscope platform coupled to the CytoViva™ 
150 Ultra Resolution Imaging (URI) System, as described in a study by Skebo et 
al. (Skebo, Grabinski, Schrand, Schlager, & Hussain, 2007).  The QImaging 
Retiga 4000R and QCapture Pro Imaging Software 6.0 were used to capture and 
store images. Mr. Craig Murdock performed the CytoViva™ analysis. 
3.13. Statistical Analysis 
After reading either the absorbance or fluorescence, the data was 
downloaded to Microsoft Excel for statistical analysis.  Each assay was 
completed in triplicate.  The data was transferred to SYS-STAT (statistical 
software) to determine statistical changes for all data compiled for the MTS and 
LDH assays.  Results for the ROS assay were analyzed using a one-way 
analysis of variance with Bonferroni multiple comparisons using SYS-9 statistical 
software. Statistical significance for all assays was determined using a 95% 
confidence interval. 
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IV. Data Description and Analysis 
4.1. Introduction 
This chapter presents the data gathered from the methodologies 
described in Chapter 3.  The data includes:  the growth curve, MTS assay (24, 
48, and 72 hour trials), LDH assay (24, 48, and 72 hour trials), and ROS assay 
(1, 4, 6, and 24 hour trials).  Also, the results from the TEM, DLS and Cyto-Viva 
are shown.  The MTS and LDH assays show the respective combined results 
after 48 hours of exposure to nanoparticles.  The 48 hour exposure timeframe 
was determined to be the most reliable time for these assays.  The ROS assay 
data includes the time data for each nanoparticle type and the compiled time 
data from the three trials.  The TEM, DLS, and Cyto-Viva show the nanoparticles 
in solution and with the A549 cell line. 
After compiling the data and observing initial trends and values in 
Microsoft Excel, the data was entered into the SYS-STAT (MTS) or SYS-9 (ROS) 
program.   This program performed the statistical analysis of the data sets. The 
p-value was set to p < 0.05.  The SYS-STAT program was used to statistically 
determine significant differences between data sets.  The program also identified 
outliers within any data sets.   
4.2. Results 
 4.2.1. Growth Curve 
The goal of the growth curve was to determine how many days it would 
take to grow 1,000,000 cells/mL starting with 100,000 cells/mL (in growth media).  
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To determine this, seven 6-well plates were seeded with 0.5 mL per well of a 
100,000 cells/mL solution of A549 cells (in growth media) on day zero.  There 
was one plate for each day for the duration of the growth curve.  Each day the 
cells were counted and an MTT assay was performed in accordance with 
Appendix B.  At day four, the growth media was changed in each remaining plate 
to ensure growth.  The data for the daily cell count and log of the daily cell count 
is seen in Table 3.  The growth curve was plotted on a logarithmic curve over 
seven days of growth as can be seen in Figure 8.  It was determined that it would 
take about seven days to grow the cells by one factor of 10.    
 
 
 
Figure 8.  Seven Day Growth Curve with Trend Line 
y = 0.5592ln(x) + 4.9674
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Figure 8 shows the greatest growth rate occurred between days three and four 
and shows a plateau effect between days four and seven.  The data for the 
number of cells is not known for days five and six for the number of cells, but still 
can be interpolated through Figure 8. 
4.2.3. MTS Assay 
 Silver nanoparticles are known to interfere with the absorbance readings.  
Therefore, 80 µL of supernatant was removed from the dosed plate (from each 
well) and placed in new plate to read the absorbance at 490 nm without 
interference from nanoparticles in solution.  Initially, a preliminary trial was 
completed at 24 hours of nanoparticle exposure, 48 hours of nanoparticle 
exposure, and 72 hours of nanoparticle exposure.  This was done to determine 
the best exposure duration. It was determined from those results, that 48 hours 
of exposure to nanoparticles was the best fit for the amount of exposure time.  
Figures 9 through 11 show the data compiled from the different time trials 
conducted: 24, 48, and 72 hours, respectively. 
The 24 hour exposure time did not show a strong response through the 
absorbance change from the control (% MTS reduction) during the assay.  The 
difference from the control medium was not significant enough at this time frame 
at all nanoparticle solutions.  Only the uncoated 5nm showed a strong change in 
absorbance with increasing concentration.  The difference from the control was 
generally less than 20% reduction across the board (except with the uncoated, 5 
nm – 200 µg/mL solution), as can be seen with Figure 9.   This time trial also 
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showed variance from what was expected to occur during this assay.  Instead of 
a steady decrease across the concentrations for each nanoparticle type, some 
increased with respect to percent control MTS reduction.   
 
 
Figure 9.  MTS Assay - 24 Hour Exposure 
 
The 48 hour exposure time trial results are shown in Figure 10.  The 48 
hour exposure time trial showed that the lung cells were exposed to the toxic 
effects of the nanoparticles for the appropriate duration.  There was a significant 
change of the toxicity over time without the cell death effect seen in the 72 hour 
trial. The trend showed what was expected with respect to concentration 
dependent toxicity; a steady decrease across increasing concentrations for each 
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nanoparticle.  It can be observed that as the concentration of the separate 
nanoparticles increase, so does the toxicity to the cells.  Also, in this time trial, as 
opposed to the 72 hour trial, there appeared to be enough viable cells remaining 
at all concentrations of each nanoparticle to expect that this would be the case 
during the further testing at this exposure duration. 
 
 
Figure 10.  MTS Assay - 48 Hour Exposure 
 
The 72 hour exposure time trial indicated that the cells received too 
extensive an exposure from the nanoparticles, as can be seen in Figure 11.  The 
cells were essentially killed by the length of nanoparticle exposure at the 100 and 
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nanoparticles sizes showed similar results, indicating cell death at this 
concentration.  Because of this increased cell death, when compared to the other 
two time trials and due to exposure length, this was determined not to be the 
optimal duration to expose the cells to the nanoparticles. 
 
 
Figure 11.  MTS Assay - 72 Hour Exposure 
 
After determining that 48 hours was the best timeframe, the results were 
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that the mitochondrial function of the cells decreased.  This is shown through the 
Percent MTS Reduction of the formazan in the cells. The mitochondria were not 
available for the reduction, which implies that cell death had occurred.   
With respect to nanoparticle size affecting toxicity, it is observed that the 
larger of the nanoparticles, in the coated and uncoated category, tended to be 
less toxic than its smaller counterpart.  The uncoated 5nm silver nanoparticles 
showed the greatest toxicity to the human lung cells, with essentially complete 
cell death at 200 µg/mL concentrations.  The uncoated 80nm concentrations 
showed less toxicity than the uncoated 5nm.  The uncoated 80nm showed about 
1.5 times less toxicity at the higher two concentrations than its 5nm counterpart.  
The coated nanoparticles, both 10nm and 80nm, showed approximately equal 
toxicity at the 200µg/mL concentrations.  The toxicity of the coated nanoparticles 
remained within a range of 10% MTS reduction percentage of each other at each 
different concentration.   
  Another significant difference in the MTS reduction assay was the 
difference between the coated and uncoated nanoparticles.    The uncoated 
nanoparticles clearly show more toxicity than the coated nanoparticles, as can be 
observed in Figure 12.  With the two larger nanoparticles, 80nm, the coated 
remained about 15-20% greater MTS reduction than its uncoated counterpart 
through the differing nanoparticle concentrations.  This indicated that the coated 
nanoparticle is less toxic to the cells than the uncoated nanoparticles. 
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Figure 12.  Combined MTS Assay Results - 48 Hour Exposure – (*) indicate statistically 
significant variation from the control 
  
With the two smaller nanoparticles (5 and 10 nm), the uncoated 
nanoparticle (5 nm) begins with a 10% decrease difference in MTS reduction at 
10 µg/mL with respect to the 10 nm coated at the same concentration.  At the 50 
µg/mL concentration, this difference more than doubles to almost 25% decrease 
difference in MTS reduction. The difference between the MTS reduction still 
increases at the 100 µg/mL to approximately a 40% MTS reduction decrease 
difference with the uncoated 5 nm showing increased toxicity with the increased 
concentration.  The uncoated 5 nm indicated almost complete cell death by the 
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200 µg/mL concentration, whereas the 10nm coated indicated that about half the 
cells were still viable at the same concentration. 
The stars indicate where there is a statistically significant difference 
between the results of the nanoparticle effects with respect to the control 
(ρ<0.05).  The uncoated 5nm silver nanoparticles show significant toxic effects at 
concentrations greater than or equal to 50 µg/mL.  The uncoated 80nm silver 
nanoparticles show significant toxicity at concentrations greater than or equal to 
100 µg/mL.  The coated nanoparticles, both 10nm and 80nm, require at least 200 
µg/mL before significant toxicity occurs to the lung epithelial cells. 
4.2.4. LDH Assay 
Like the MTS assay, silver nanoparticles have shown to interfere with the 
absorbance readings.  Therefore, 80 µL of supernatant was removed from the 
dosed plate (from each well) and placed in new plate to read the absorbance at 
490nm without interference from nanoparticles in solution.  This assay was 
completed in conjunction with the MTS assays.  Appendix E describes the step 
by step instruction of this assay. 
Initially, a preliminary trial was completed at 24 hours, 48 hours, and 72 
hours of nanoparticle exposure. This was done to determine the best exposure 
duration. It was determined from those results that 48 hours of exposure to 
nanoparticles was to be used for the exposure duration.  Figures 13 through 15 
show the data compiled from the different time trials conducted: 24, 48, and 72 
hours, respectively.  It was expected that, if the MTS assay showed greatest 
toxicity at the highest concentrations (low MTS reduction); then, the LDH assay 
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should indicate high leakage (% LDH leakage to media) at corresponding 
concentrations.   
 The 24 hour time trial was not chosen as the optimal amount of exposure 
time for this assay, because the response from the absorbance was minimal.  As 
seen in Figure 13, the leakage percentage was minimal across the nanoparticle 
concentrations, except for the uncoated 5 nm nanoparticles.  Further exposure 
was needed to achieve the expected result.  As the nanoparticle concentration 
increased, it would be expected that the LDH leakage into the media would also 
increase.  The 24 hours of exposure time trial did not show this to be the result 
for all nanoparticles, as seen in Figure 13. 
 
 
Figure 13.  LDH Assay - 24 Hour Exposure 
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The 48 hour time trial was chosen as the amount of time to expose the 
lung cells.  The results of this time trial are found in Figure 14.  Although it still did 
not show the concentration dependent increase in LDH leakage, this assay was 
completed with the MTS assay which was completed after 48 hours of exposure.   
The equal time of nanoparticle exposure also was needed for an equal 
comparison of results between the LDH and MTS assays.  
   
 
Figure 14.  LDH Assay - 48 Hour Exposure 
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no significant change in the absorbance at any nanoparticle concentration.  This 
exposure time was not chosen due to this. 
 
 
Figure 15:  LDH Assay - 72 Hour Exposure 
Three separate trials were completed with the 48 hour nanoparticle 
exposure.   The 48 hour time point was chosen to have a direct comparison to 
the MTS assay.  The results of the 48 hour exposure trials are graphed in Figure 
16.  Again, it was observed that the LDH leakage is decreasing across the 
concentrations instead of increasing.  From other trials on different nanoparticles, 
it was expected that as the concentration of the nanoparticle solution increased, 
so would the percent leakage of LDH into the media.  This would be an indicator 
of the toxicity of the nanoparticles to the cell membrane.   
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Figure 16.  Combined LDH Assay Results - 48 Hour Exposure 
Because the results were not what would be expected with this type of 
assay, it was determined that this was not a reliable assay to determine toxicity 
of the silver nanoparticles with this cell line.  It is suspected that the nanoparticles 
may interfere with the LDH media or the LDH enzyme with the A549 cells.  Also, 
it can be inferred that the silver nanoparticles are killing the lung cells; therefore 
there is no leakage of the LDH to the media occurring.  This can be inferred while 
comparing the MTS results to the LDH results.  It is observed through the MTS 
assay that there was increased cell death occurring at the higher concentrations 
of silver nanoparticles.   
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4.2.5. ROS Assay 
The exposure media and growth media used for the ROS testing is 
different than the media used in the other assays.  The media used during this 
testing have no phenol red coloring in them.  The phenol red has been 
associated with interference with the fluorescence readings required for this type 
of testing.  Therefore, in order to have a ‘clean’ reading, media without phenol 
red is needed.  The details of these solution are described in Appendix F.  
Trials were completed after initial dosing (0 hour), 1 hour, 4 hours, 6 
hours, and 24 hours.  The procedure used was adapted from in Wang & Joseph 
(1999) and described in Appendix F.  Instead of reading the same plate for all 
readings as indicated in their procedure, one 96-well plate was prepared for each 
time point.  Figure 17 shows an example of a black well plate after 1 hour of 
incubation.  
 
 
Figure 17.  96-Well Black Plate for ROS Assay after 1 Hour Incubation 
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After an initial fluorescence reading of each plate, 80 µL of supernatant 
was transferred from the original plate to a new plate to be read without the 
nanoparticle interference.  Three trials at each time point were completed.  The 
data was compiled by time point and each different nanoparticle type.  Figures 
18-21 show the compiled results of the 3 separate ROS trials by each different 
nanoparticle type at each time point that a reading was taken.   
Figure 18 shows the results from the uncoated 5nm silver nanoparticle for 
the ROS assay.  It shows that there is a 3-fold increase with respect to the 
control (fluorescence).   The ROS formation peaked at this time point and 
steadily decreased with increase exposure time.  There is also an inverse 
proportionality between the nanoparticle concentration and ROS formation:  the 
lower the concentration, the higher the formation of ROS in the cell line.  A higher  
ROS fluorescence reading is observed at the lower concentration of the 
uncoated 5nm than at the higher concentration.  At all time points after the initial 
reading, fluorescence indicates that ROS have been formed at all concentrations.  
At 10 µg/mL, the uncoated 5nm nanoparticles show that they form ROS as 
quickly as one hour after dosing the cells.   
After conducting statistical analysis on the data, it was determined that 
there were only two significant peaks; at 1 hour and with the 10 and 50 µg/mL 
concentrations.  Other peaks did not show statistical differences.  This is due to 
the range that the results of each (of the other) peak spanned.  The standard 
deviation of the data and the data means did not give statistical differences with 
the control means. 
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Figure 18.  Reactive Oxygen Species Results for Uncoated 5 nm - (*) indicate statistically 
significant variation from the control 
  
Figure 19 shows the results for the coated 10 nm silver nanoparticles.  
These nanoparticles do not show the same fold difference as the 5 nm silver 
nanoparticles; however the coated 10 nm still shows that ROS are formed after 
the cells are dosed with the nanoparticles.  The coated 10 nm reach a peak at 
about 2-fold the fluorescence of the control.  The coated 10 nm show its greatest 
fold difference with the control with the 50 µg/mL concentration at the 1 hour time 
points, which is the only statistically significant peak for this nanoparticle.   Other 
peaks did not show statistical differences.  This is due to the range that the 
results of each (of the other) peak spanned.  The standard deviation of the data 
and the data means did not give statistical differences with the control means. 
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Figure 19.  Reactive Oxygen Species Results for Coated 10 nm - (*) indicate statistically 
significant variation from the control 
 
 Figure 20 shows the results for the uncoated 80 nm silver nanoparticles.  
Like the uncoated 5 nm silver nanoparticles, the lowest concentration indicated 
that ROS formation occurred upon dosing the cells with the nanoparticle, though 
only slightly (about 0.2-fold difference with control).  For the 10 and 50 µg/mL 
concentrations, the fold difference peaks out at 1.5 fold-difference (with respect 
to the control) at the 1 hour time point and maintain around that value for both the 
4 and 6 hour time points.  The higher two concentrations, 100 and 200 µg/mL, 
show peak fold-difference at the 24 hour time point.  At the higher 
concentrations, it is observed that it takes longer to have significant change in 
ROS concentration than with the lower concentration of the same nanoparticle.  
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The only significant peak was at the 10 µg/mL with one hour of exposure.  Other 
peaks did not show statistical differences.  This is due to the range that the 
results of each (of the other) peak spanned.  The standard deviation of the data 
and the data means did not give statistical differences with the control means. 
 
 
 
Figure 20.  Reactive Oxygen Species Results Uncoated 80 nm - (*) indicate statistically 
significant variation from the control 
 
Figure 21 shows the results for the coated 80 nm silver nanoparticles.  
The 80 nm coated nanoparticles show similar ROS formation results compared 
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nanoparticles (80 nm) show less toxicity than the smaller respective 
nanoparticles (5 and 10 nm).   
After conducting statistical analysis on the data, it was determined that 
there were no significant peaks.  Other peaks did not show statistical differences.  
This is due to the range that the results of each (of the other) peak spanned.  The 
variation of the data means did not give statistical differences with the control 
means. 
 
 
 
Figure 21.  Reactive Oxygen Species Assay Results for Coated 80 nm 
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and coated 10 nm nanoparticles show a higher formation of ROS than either of 
the 80 nm nanoparticles.  This is an indication that the smaller nanoparticles are 
more toxic than the larger respective nanoparticles.  The concentration of the 
nanoparticles affects the ROS formation.  With the 5 nm nanoparticles, the 
lowest concentration shows the highest ROS formation; the ROS formation 
(toxicity) decreases with an increasing concentration of the nanoparticle.  
Similarly, the coated 10 nm has the highest ROS formation at 50 µg/mL, then the 
levels of ROS formation decrease with increasing concentration.    
After statistical analysis, no peaks for the coated 80nm silver 
nanoparticles were determined to be statistically significant. 
The statistical analysis for the ROS assay data were analyzed using a 
one-way analysis of variance with Bonferroni multiple comparisons (Rosner, 
1990). The statistical analysis was completed by Dr. Latha Narayanan using 
SYS-9 software and a confidence interval of 95% (ρ < 0.05).  
4.3. Dynamic Light Scattering and Transmission Electron Microscopy 
Figure 22 shows the TEM primary particles size and distribution 
determined from measurement of over 100 particles from random fields of view.  
Dynamic Light Scattering (DLS) results are shown in Table 4.  DLS z-average 
particle diameter in solution and LDV zeta potential measurements were 
measured at sample concentrations of 50 µg/mL of each different nanoparticle 
used in this study.  
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Figure 22.  Transmission Electron Microscope Images of Ag Nanoparticles.  Images were 
taken at 100 kV and 100 kx magnification on a formvar-carbon coated Cu grid.  (A) Ag 5 nm 
uncoated.  (B) Ag 80 nm uncoated.  (C)  Ag 10 nm coated.  (D) Ag 80 nm coated  
 
Table 4 shows the TEM primary particles size and distribution determined from 
measurement of over 100 particles from random fields of view.  It also shows the 
DLS z-average particle diameter in solution and LDV zeta potential 
measurements were measured at sample concentrations of 50 µg/mL of each 
different nanoparticle used during this study.  The results show the average size 
of the silver nanoparticles.  The results show that the smaller nanoparticles, 
coated 5 nm and uncoated 10 nm, are larger than the size given by the 
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manufacturer.  The 80 nm nanoparticles, coated and uncoated, results indicate 
that they are smaller than the size given by the manufacturer.  The DLS particle 
diameter in solution indicates that there is little agglomeration in de-ionized 
water, but an increase in agglomeration when the nanoparticles are in exposure 
media.   
Table 3.  Characterization Data for Silver (Ag) Nanoparticles 
 
4.4. CytoViva™ 
 After exposing the A549 cells to the nanoparticles, photos were taken of 
the cells using the CytoViva™ method.  A control sample was photographed of 
the A549 cells in exposure media only, shown in Figure 23.  Figure 24 shows the 
cells interaction with the nanoparticles in exposure media. It can be observed 
through these photos that the nanoparticles do interact with the cell membrane.  
It is unclear through the use of this method whether the nanoparticles are inside 
the cells interacting with the mitochondria and the nucleus.  Other methods will 
need to be conducted to determine those interactions. 
 
LDV Zeta Potential of 
Particle Surface 
Charge (mV)
DI H2O F-12K Media DI H2O
Ag 5 nm UC 8.9 ± 2.6 30.6 (0.626) 1550 (0.272) -45.9
Ag 80 nm UC 61.2 ± 15.6 68.8 (0.240) 1710 (0.359) -13.8
Ag 10 nm C 14.7 ± 4.1 38.7 (0.532) 1930 (0.615) -37
Ag 80 nm C 65.6 ± 24.0 142 (0.145) 241 (0.400) -29
DLS Z-Average Particle Diameter in 
Solution (PdI) (nm)Particle
TEM Mean Primary 
Particle Diameter 
(±SD) (nm)
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Figure 23.  CytoViva™ Picture at 60X (60-times) magnification of the A549 Cells (10 µg/mL 
solution) 
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Figure 24.  CytoViva™ Pictures at 60X (60 times) magnification of the Silver Nanoparticles 
and the A549 Cell Line (10 µg/mL solution) – (A) Coated 10 nm, (B) Coated 80 nm, (C) 
Uncoated 5 nm, (D) Uncoated 80 nm  
4.5. Summary 
The MTS assay is a reliable assay for determining toxicity of the silver 
nanoparticles on the A549 cell line.  The assay shows that there is both a size 
and concentration dependence for the level of toxicity to the cell mitochondria.  
The ROS assay also is a reliable assay for determining the formation of ROS by 
the silver nanoparticles in the A549 cell line.  It also shows a size and 
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concentration dependent toxicity.   Both assays show that the smaller 
nanoparticles are more toxic to the cells than the larger nanoparticles.  The MTS 
assay shows increasing toxicity with increasing concentration.  In contrast, the 
ROS assay showed a higher formation of ROS with lower concentrations.  Both 
assays also indicated that the uncoated nanoparticles have a higher toxic effect 
to the cells than the coated nanoparticles.  The LDH assay did not provide 
reliable results for this cell line and the silver nanoparticles. 
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V. Conclusions and Future Research Considerations 
5.1. Overview 
This study demonstrates that silver nanoparticles are toxic to epithelial 
lung cells.  Uncoated nanoparticles appear to be more toxic than coated 
nanoparticles to the lung cell mitochondria.  The MTS assay indicates that, with 
greater concentrations the toxic effects are greater.  Also, the MTS assay 
indicates that the smaller nanoparticles appear to be more toxic than the larger 
nanoparticles (5 or 10 nm vs. 80 nm) to the cell mitochondria. 
The LDH assay was determined to be an unreliable assay to determine 
toxicity for the silver nanoparticles for this cell line.  There is an interference 
occurring, that would need further investigation.   
The ROS assay indicates that the silver nanoparticles do induce the 
formation of ROS in the cell line.  The smaller nanoparticles (uncoated 5 and 
coated 10 nm) show a higher formation of the ROS in the cells, especially at the 
lower concentrations 10 and 50 µg/mL.  At higher concentrations of these 
nanoparticles, the ROS formation is lower.  The larger nanoparticles, both coated 
and uncoated 80 nm, show similar results for ROS formation with respect to fold-
difference.  Although lower than the smaller nanoparticles, they do show 
formation of the ROS in the cell line.   
Both the MTS assay and the ROS assay are reliable assays to determine 
toxic effects of silver nanoparticles in this cell line.  The LDH assay was 
determined to be unreliable during this study.  Both the MTS and ROS assay can 
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assist in determining toxic effects of the silver nanoparticles in human lung 
epithelial cells. 
Through this study, it can be inferred that there is a mechanism of toxicity 
through mitochondrial function interference as well as through the formation of 
ROS within the cell line.   
5.2. Investigative Questions Answered 
1.  Are silver nanoparticles toxic to the A549 (ATCC) lung epithelial cells?   
From the MTS assay, it can be interpreted that the silver nanoparticles 
are, in fact toxic to the A549 lung epithelial cells.  The silver nanoparticles affect 
the mitochondrial activity within these cells negatively.  Once the mitochondria in 
the cells stop functioning, the cells begin to move to apoptosis. 
One method in which the nanoparticles cause cells to begin apoptosis is 
through the formation of reactive oxygen species.  These ROS are toxic to the 
cells and, through the ROS assay, it can be interpreted that the silver 
nanoparticles cause toxicity to the cells through the formation of ROS.  From the 
results of the ROS assay, it can be determined that the uncoated nanoparticles 
are more toxic to the cells than the coated nanoparticles.  Also, that the smaller 
of the nanoparticles, whether coated or uncoated, is more toxic to the cell line.   
 2.  Does the exterior coating of the nanoparticles affect toxicity? 
 By looking at both the MTS assay and the ROS assay, it can be observed 
that the coating of the nanoparticles does affect the toxicity of the nanoparticle.  
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The MTS assay indicates that the uncoated nanoparticles are much more toxic 
than the coated nanoparticles.   
This is supported through the ROS assay results.  It can be observed that 
the uncoated nanoparticles are more toxic to the cell line than the uncoated 
nanoparticles.  This is more the case between the smaller of the two types of 
nanoparticles (uncoated 5 nm and coated 10 nm), than for the 80 nm 
nanoparticles.  The 80 nm nanoparticles show similar formation of ROS with 
respect to the fold difference with the control across all time points.  With the 
smaller nanoparticles, the uncoated 5 nm shows to have a higher formation of 
ROS within the cell line, especially in the earlier time points.  
3.  Does the size difference of the nanoparticles affect toxicity? 
By looking at the MTS assay, it is clear that the size of the nanoparticle 
matters, with respect to its toxic effects.  The smaller nanoparticles show a lower 
percent MTS reduction than their larger counterpart at all concentrations. 
This is also supported through the results of the ROS assay.   The ROS 
assay shows that the uncoated 5 nm and coated 10 nm silver nanoparticles 
induce a greater formation of ROS than the uncoated and coated 80 nm 
nanoparticles.  
5.3. Recommendations for Future Research 
As the future of technology shifts into the greater use of the nanoparticles, 
it is important to acknowledge that these nanoparticles can also cause toxic 
effects to human health.  Future research should include a more in-depth study 
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into the mechanisms of toxicity.  From this study, it can be inferred that toxic 
mechanisms of silver nanoparticle are through interruption of mitochondrial 
function as well as the formation of the ROS within the lung cells.  The study of 
lung cells is becoming increasingly important since the silver nanoparticles are 
being used industrially more than ever; therefore, the inhalation exposure will be 
increasing.  Also, there are products on the market that are aerosol disinfectant 
sprays that incorporate the use of silver nanoparticles as the disinfectant (Fauss, 
2008).    
The aerosol use of silver nanoparticles is increasing both in industrial 
settings and in the public market, understanding the level at which the toxic 
effects of silver nanoparticles are lethal will be more important than ever.  This 
can also include understanding how this will affect the world of bioterrorism, both 
in defense and detection.  As seen earlier, the DoD, ISN and MIT are delving into 
the realm of nanoparticle use for the defense and detection.  Silver nanoparticles 
may be able to be used for these types of methods for the warfighter.  The 
knowledge base of its toxicity will need to be built further than its current state. 
An assay that can be used in further studies is the apoptosis assay to 
determine the concentrations and times that apoptosis is occurring.  This can be 
used instead of the LDH assay, which was unreliable in this study.  Also, this 
assay can assist in the further determination of the lethal concentration of silver 
nanoparticles and at what time point that apoptosis of the cells may occur. 
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Appendix A:  Cell Culturing and Splitting 
 
A549 Cell Line:  Human lung epithelial cells, ATCC® (Manassas, VA) 
Growth Media:  F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 10% 
fetal bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) Solution, ATCC® 
(Manassas, VA) 
PBS:  1% Phosphate Buffer Serum 
1. Aspirate culture medium from 75 mL flask. 
2. Rinse with 5.0 mL PBS. 
3. Aspirate PBS. 
4. Add 2.0 mL 0.25% Trypsin with EDTA solution to flask ensuring complete 
coverage of bottom of flask. 
5. Incubate for 4-5 minutes in 37°C incubator, or until the cells have 
unattached from the bottom of the flask (cells will appear spherical under a 
light microscope). 
6. Add 5.0 mL growth media to flask and break apart the cells by pipetting 
the solution in and out of the pipette.  
7. Count the cells using a standard hemocytometer and light microscope. 
a. Pipette 10 µL of the cell solution onto the hemocytometer 
b. Count cells in each quadrant under a light microscope.  The 
average count from all quadrants indicates the number of cells per 
milliliter of solution times 104. 
 
8. In a new flask add 1.0 mL of the cell culture to 10.0 mL of growth media.  
Incubate 3-4 days at 37°C. 
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Appendix B:  Cell Growth Curve Procedure 
 
Acidified IPA:  solution of 198.36 mL d-H2O, 1.64 mL concentrated hydrochloric 
acid (HCl), and 300 mL Isopropyl Alcohol 
MTT Solution:  10 mg MTT powder dissolved in 20 mL PBS 
1. This procedure is started on a day when the cells are split. 
2. In a 6 well culture plate (one for each day of the growth curve duration), 
add 0.5 mL of a 50,000 cells/mL solution.   
3. Incubate each plate for the number of hours/days indicated 
(24hours/1day, 48hours/2days, etc.). 
4. On the day that the plate is read: 
a. For wells 1-3:   
i. Aspirate media. 
ii. Wash each well with 0.5 mL PBS, then aspirate PBS. 
iii. Add 0.25% Trypsin with EDTA solution, incubate 4 - 5 
minutes. 
iv. Add 0.5 mL Growth Media to each well, break cells using a 
pipette. 
v. Mix all 3 wells in a vial and count cells using a 
hemocytometer. 
b. For wells 4-6 
i. Aspirate media. 
ii. Wash with 0.5 mL PBS and then aspirate PBS. 
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iii. Add 0.5 mL of MTT Solution to each well, incubate 30 
minutes. 
iv. Aspirate media.  Add 0.5 mL of Acidified IPA to each well. 
v. Shake the plate vigorously for 10 minutes on shaker. 
vi. Remove 200 µL into a 96-well plate to read absorbance at 
490 nm. 
5.  Record the Cell Count and Absorbance. 
6.  Repeat as needed over the duration of the Growth Curve Period.
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Appendix C:  MTT Assay 
 
Exposure Media:  F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1% 
Penicillin/Streptomycin (P/S), ATCC® (Manassas, VA) 
Acidified IPA:  solution of 198.36 mL d-H2O, 1.64 mL concentrated hydrochloric 
acid (HCl), and 300 mL Isopropyl Alcohol 
MTT Solution:  10 mg MTT powder dissolved in 20 mL PBS 
Day 1:  Seeding the Cells 
1. Follow the procedure for cell culturing.   
2. After counting the cells, make a solution that has 200,000 cells/mL in 
growth media.   
3. In a 24 well plate, add 0.5 mL to each well that is being used.  Each well 
was marked with which type of nanoparticle and the dilution factor. 
4. Incubate at 37°C for 24 hours.  
 
Table 4.  Example of 24-well MTT Plate 
 
 
 
1 2 3 4 5 6
BLK 5nm Unctd 5nm Unctd BLK 80nm Uctd 80nm Uctd
100ug/mL 200ug/mL 100ug/mL 200ug/mL
BLK 5nm Unctd 5nm Unctd BLK 80nm Uctd 80nm Uctd
100ug/mL 200ug/mL 100ug/mL 200ug/mL
BLK 5nm Unctd 5nm Unctd BLK 80nm Uctd 80nm Uctd
100ug/mL 200ug/mL 100ug/mL 200ug/mL
BLK 5nm Unctd 5nm Unctd BLK 80nm Uctd 80nm Uctd
100ug/mL 200ug/mL 100ug/mL 200ug/mL
A
B
C
D
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Day 2:  Dosing the Cells 
1.  Aspirate media from the wells and wash with 0.5 mL per well with PBS. 
2. Aspirate PBS. 
3. Before adding nanoparticles into solution, sonicate for 10 seconds. 
4. Add 0.5 mL of each nanoparticle dosing solution into the appropriate well.  
Use exposure media to wells with 0 µg/mL nanoparticle solution.   
Day 3:  MTT 
1.  Ensure MTT Solution is at room temperature before using.   
2. Aspirate media from wells and wash with 0.5 mL per well with PBS.   
3. Add 0.5 mL of MTT solution to each well. 
4. Cover plates and incubate for 30 minutes for color change. 
5. Aspirate media. 
6. Add 0.5 mL per well of acidified IPA.  Place covered on shaker for 10 
minutes to ensure that everything is in solution. 
7. Remove 200 µL from each well and transfer to 96 well plate.   
8. Read absorbance at 490 nm. 
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Appendix D:  MTS Assay 
 
Exposure Media:  F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1% 
Penicillin/Streptomycin (P/S), ATCC® (Manassas, VA) 
MTS Solution:  CellTiter96® AQueous One Solution Reagent for the CellTiter 96
® 
AQueous One Solution Cell Proliferation Assay from Promega 
Day 1:  Seeding the cells 
1. Follow the procedure for cell culturing.   
2. After counting the cells, make a 23.0 mL solution that has 200,000 
cells/mL in growth media.   
3. In a 96 well plate, add 200 µL of the cell solution to each well that is being 
used.  Each well should be marked with which type of nanoparticle and the 
dilution factor. 
4. Incubate at 37°C for 24 hours. 
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Table 5.  Example of a 96-Well Plate 
 
 
Day 2:  Addition of Dosing Solution 
1. After 24 hours of incubation, aspirate media out of the plate. 
2. Wash with 200 µL of PBS using multi-well pipette.  Aspirate PBS. 
3. Before adding the nanoparticles into solution, sonicate for 10 seconds. 
4. Add 200 µL of dosing solutions or exposure media. 
a. Dosing solutions in accordance with appropriate dilutions. 
b. Exposure media is the control. 
5. Incubate 24 hours in 37°C incubator. 
 
 
1 2 3 4 5 6 7 8 9 10 11 12
A blank
10ug/mL
5nm, uc
50ug/mL
5nm, uc
100ug/mL
5nm, uc
200ug/mL
5nm, uc blank
10ug/mL
10nm, c
50ug/mL
10nm, c
100ug/mL
10nm, c
200ug/mL
10nm, c
B blank
10ug/mL
5nm, uc
50ug/mL
5nm, uc
100ug/mL
5nm, uc
200ug/mL
5nm, uc blank
10ug/mL
10nm, c
50ug/mL
10nm, c
100ug/mL
10nm, c
200ug/mL
10nm, c
C blank
10ug/mL
5nm, uc
50ug/mL
5nm, uc
100ug/mL
5nm, uc
200ug/mL
5nm, uc blank
10ug/mL
10nm, c
50ug/mL
10nm, c
100ug/mL
10nm, c
200ug/mL
10nm, c
D blank
10ug/mL
5nm, uc
50ug/mL
5nm, uc
100ug/mL
5nm, uc
200ug/mL
5nm, uc blank
10ug/mL
10nm, c
50ug/mL
10nm, c
100ug/mL
10nm, c
200ug/mL
10nm, c
E blank
10ug/mL
80nm, uc
50ug/mL
80nm, uc
100ug/mL
80nm, uc
200ug/mL
80nm, uc blank
10ug/mL
80nm, c
50ug/mL
80nm, c
100ug/mL
80nm, c
200ug/mL
80nm, c
F blank
10ug/mL
80nm, uc
50ug/mL
80nm, uc
100ug/mL
80nm, uc
200ug/mL
80nm, uc blank
10ug/mL
80nm, c
50ug/mL
80nm, c
100ug/mL
80nm, c
200ug/mL
80nm, c
G blank
10ug/mL
80nm, uc
50ug/mL
80nm, uc
100ug/mL
80nm, uc
200ug/mL
80nm, uc blank
10ug/mL
80nm, c
50ug/mL
80nm, c
100ug/mL
80nm, c
200ug/mL
80nm, c
H blank
10ug/mL
80nm, uc
50ug/mL
80nm, uc
100ug/mL
80nm, uc
200ug/mL
80nm, uc blank
10ug/mL
80nm, c
50ug/mL
80nm, c
100ug/mL
80nm, c
200ug/mL
80nm, c
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Table 6.  Dosing solution calculations (1mL Solution) 
For a 1 mL Solution: 
  
Concentration 
Exposure Media 
(mL) 
Ag NP (µL of a 
1mg/mL solution) 
10µg/mL 0.990 10 
50µg/mL 0.950 50 
100µg/mL 0.900 100 
200µg/mL 0.800 200 
 
Day 3:  MTS  
1.  After 24-hour incubation, aspirate exposure media. 
2. Wash cells with room temperature PBS 1-2 times to remove any 
nanoparticles not in the cells. 
3. Make a mixture of 20 µL MTS reagent plus 100 µL exposure media for 
each well.   
4. Add 120 µL of the mixture to each well using a multi-channel pipette. 
5. Shake gently to mix well. 
6. Incubate at 37°C for 1-4 hours (the reagent is yellow and will turn orangey 
red to dark red depending on the amount of proliferation).  It should be checked 
every hour to determine when it needs to be read.   
7. After incubation, put on shaker briefly to ensure that everything is evenly 
mixed. 
8. Read absorbance at 490 nm. 
9. Transfer 80 µL of each well to a new plate and read absorbance at 490 
nm.  This is to ensure that there is no background due to nanoparticles. 
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Appendix E:  Lactate Dehydrogenase (LDH) Assay  
 
LDH Materials: Promega CytoTox 96® Non-Radioactive Cytotoxicity Assay Kit  
Exposure Media:  F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1% 
P/S, ATCC® (Manassas, VA) 
Positive Control:  Cadmium Oxide Nanoparticles 
Day 1:  Seeding the cells 
1.  Follow the procedure for cell culturing.   
2. After counting the cells, make a solution that has 200,000 cells/mL in 
growth media.   
3. In a 96 well plate, add 200 µL to each well that is being used.  Each 
section should be marked with which type of nanoparticle and the dilution factor, 
to include the positive Control, on the lid. 
4. Incubate at 37°C for 24 hours. 
Day 2:  Addition of Dosing Solution 
1. After 24 hours of incubation, aspirate media out of the plate. 
2. Wash with 200 µL of PBS using multi-well pipette.  Aspirate PBS. 
3. Add 200 µL of dosing solutions or exposure media. 
a. Dosing solutions in accordance with appropriate dilutions. 
b. Exposure media is the control. 
4. Add 200 µL of positive control solutions into appropriate wells. 
5. Incubate 24 hours in 37°C incubator. 
Day 3:   
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1.  Remove 50 µL of media from the 96-well plate that has been incubating 
and place into a new 96-well plate. 
2.  Add 50 µL of exposure media to each well using a multi channel pipette. 
3.  Add 50 µL of LDH assay buffer solution into each well.  (add 12.0 mL 
buffer solution to solute powder bottle – in kit) 
4.  Incubate at room temperature for 30 minutes in the dark (can cover with 
foil).   
5.  After 30 minutes add 50 µL of Stop Solution to each well. 
6.  Read absorbance at 490 nm immediately. 
 
If combining with MTS Assay, also on day 3: 
1.  After completing the LDH portion of the testing, aspirate the media from 
the original plate. 
2.  Wash the wells 3 times with 200 µL PBS using a multi-channel pipette. 
3.  Add 120 µL of exposure media and MTS solution to each well (100:20 µL 
ratio). 
4. Incubate at 37°C for 1-4 hours, watching for color change.   
5. Read absorbance at 490 nm.   
6. Remove 80 µL from each well and transfer to new plate.  Read 
absorbance at 490 nm.  
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Appendix F:  Reactive Oxygen Species (ROS) Assay 
 
DCHF-DA:  2’,7’– dichlorodihydrofluorescein diacetate, Invitrogen, Lot 478251, 
100mg quantities 
DMSO:  Dimethyl Sulfoxide 
Positive Control:  30% H2O2 dilutions 
Growth/Exposure Media:  Dulbecco’s Modified Eagle Medium/Nutrient (without 
Phenol Red) Mixture, F-12 Ham solution was prepared in accordance with the 
accompanying instructions.  The growth media required the addition of 10% fetal 
bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) Solution.  The 
exposure media required a 1% Penicillin/Streptomycin (P/S) Solution addition. 
 
1. Seed cells in 96-well black plate (approximately 150,000 cells/mL solution) 
with 200 µL per well. 
2. Incubate at 37°C for 48 hours. 
3. Prepare reagents: 
a. DCHF-DA (mw 487.3): 48 mg in 10 mL DMSO = 10 mM 
i. Add 50 μL of stock solution into 5 mL growth media, to yield 
a 100 μM DCFH-DA solution.  For one 96-well plate, a 23 
mL solution is needed. 
 
b. Positive control (H2O2) 
i. Add 114 μL of H2O2 into 10 mL of PBS to yield a 100 mM 
Solution of H2O2. 
ii. Prepare dosing concentration for positive control in exposure 
media (500 μM – 2 mM). 
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4. After incubation, aspirate media from wells and wash with 200 µL PBS for 
each well. 
5. Under dark conditions: 
a. Add 200 µL of 100 µM DCFH-DA in growth media, incubate 20-30 
minutes. 
b. Aspirate media with DCFH-DA and wash with 200 µL PBS. 
c. Add 200 µL of positive control or dosing solution and cover plates 
with aluminum foil. 
i. Make dosing solution with the required nanoparticle 
concentrations; e.g. 10 µg/mL, 50 µg/mL, 100 µg/mL 
ii. Positive control solution can have differing concentrations of 
H2O2; e.g.10 mM solution, 1 mM solution, 0.1 mM solution, 
0.01 mM solution. 
 
d. Read background fluorescence values. 
e. Place the plate in the incubator. 
f. Measure fluorescence of the cells at excitation 485 nm and 
emission at 530 nm at specified hour time points (e.g. 1, 4, 6, 24 
hours). 
g. Remove 80 µL of supernatant from each well and transfer to a new 
96-well plate.  Read fluorescence.  
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